Asuterasuzhi Yao K.K.
Romanizedアステラス製薬株式会社· Corporate Number: 5010001034966
About this English name
Auto-romanized from the registered Japanese kana reading. Not an officially registered English name.
For sanctions screening or contractual purposes, always cross-reference using the Corporate Number (法人番号) shown above, not the English name.
Enforcement records (3)
- Oct 5, 2017先駆け審査指定制度対象品目の募集薬事法Ministry of Health, Labour and Welfare
ASP2215 for initial relapse or treatment-resistant FLT3 gene mutation-positive acute myeloid leukemia
- Oct 5, 2017先駆け審査指定制度対象品目の募集Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and Welfare
The Ministry of Health, Labour and Welfare established the 'Designated Priority Review System' on April 1, 2015, to promote the development of innovative pharmaceuticals, medical devices, regenerative medicine products, etc., with the aim of facilitating their early practical use in Japan.
- Oct 27, 2015Administrative GuidanceAct on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and Welfare
The Ministry of Health, Labour and Welfare evaluated 50 pharmaceutical products for which designation applications were submitted in August this year, and today designated six of these products as subject to the 'Pioneering Review Designation System' for the first time.
Watch this company
Get an email when Asuterasuzhi Yao K.K. has new enforcement actions or registry changes. Sign-in is via a one-time email link — no password required.
Language
日本語版を見る (Japanese)Registry data
- Corporate Number (法人番号)
- 5010001034966
- Registered address
- 東京都中央区日本橋本町２丁目５番１号
- Status
- Active
For compliance use
This profile aggregates public Japanese government records. Always cross-reference the Corporate Number when matching this entity in your systems — Japanese English company names are often inconsistent across sources.